Cargando…
Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study
INTRODUCTION: The present study investigated hospitalization data of patients receiving radiotherapy at Anhui Cancer Hospital during the COVID-19 epidemic and analyzed the impact of the epidemic on the clinical data of radiotherapy patients to provide references for the feasibility and safety of rad...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800447/ https://www.ncbi.nlm.nih.gov/pubmed/33442292 http://dx.doi.org/10.2147/CMAR.S281323 |
_version_ | 1783635355937800192 |
---|---|
author | He, Jian Yang, Liping Tao, Zhenchao Yang, Jing Zhou, Yan Wang, Ru Zhang, Yangyang Huang, Yifan Zhou, Lingran Sun, Bin Gao, Jin |
author_facet | He, Jian Yang, Liping Tao, Zhenchao Yang, Jing Zhou, Yan Wang, Ru Zhang, Yangyang Huang, Yifan Zhou, Lingran Sun, Bin Gao, Jin |
author_sort | He, Jian |
collection | PubMed |
description | INTRODUCTION: The present study investigated hospitalization data of patients receiving radiotherapy at Anhui Cancer Hospital during the COVID-19 epidemic and analyzed the impact of the epidemic on the clinical data of radiotherapy patients to provide references for the feasibility and safety of radiotherapy at other medical institutions. METHODS: The present study performed a retrospective analysis of hospitalization data of patients undergoing radiotherapy at the Radiation Department (from January 5 to March 19, 2020 according to the Chinese lunar calendar), who were defined as the epidemic group. Hospitalization data for patients undergoing radiotherapy during the same period in 2019 were used as the control group for comparison with the epidemic group in terms of sex, age, distribution of various cancer types, hospitalization costs, average length of stay, completion rate of radiotherapy, treatment mode, and purpose of radiotherapy. RESULTS: A total of 79 and 115 patients received radiotherapy in the epidemic group and control group, respectively. The number of patients who received radiotherapy declined 31.3% during the epidemic period. The number of head and neck cancer patients who received radiotherapy was 36 (45.57%) in the epidemic group and 32 (27.83%) in the control group, which was a significant difference (χ(2)=6.476, P=0.011). The proportions of patients with other types of cancer decreased, with no significant difference between the two groups (P>0.05). No significant differences between the two groups were found in terms of other hospitalization data (P>0.05). CONCLUSION: The total number of patients who received radiotherapy decreased during the epidemic period, but the proportion of head and neck cancer increased. The epidemic had no significant effect on other hospitalization data. While strengthening prevention and control measures, we should actively perform radiotherapy to ensure that cancer patients receive timely and safe treatment. |
format | Online Article Text |
id | pubmed-7800447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78004472021-01-12 Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study He, Jian Yang, Liping Tao, Zhenchao Yang, Jing Zhou, Yan Wang, Ru Zhang, Yangyang Huang, Yifan Zhou, Lingran Sun, Bin Gao, Jin Cancer Manag Res Original Research INTRODUCTION: The present study investigated hospitalization data of patients receiving radiotherapy at Anhui Cancer Hospital during the COVID-19 epidemic and analyzed the impact of the epidemic on the clinical data of radiotherapy patients to provide references for the feasibility and safety of radiotherapy at other medical institutions. METHODS: The present study performed a retrospective analysis of hospitalization data of patients undergoing radiotherapy at the Radiation Department (from January 5 to March 19, 2020 according to the Chinese lunar calendar), who were defined as the epidemic group. Hospitalization data for patients undergoing radiotherapy during the same period in 2019 were used as the control group for comparison with the epidemic group in terms of sex, age, distribution of various cancer types, hospitalization costs, average length of stay, completion rate of radiotherapy, treatment mode, and purpose of radiotherapy. RESULTS: A total of 79 and 115 patients received radiotherapy in the epidemic group and control group, respectively. The number of patients who received radiotherapy declined 31.3% during the epidemic period. The number of head and neck cancer patients who received radiotherapy was 36 (45.57%) in the epidemic group and 32 (27.83%) in the control group, which was a significant difference (χ(2)=6.476, P=0.011). The proportions of patients with other types of cancer decreased, with no significant difference between the two groups (P>0.05). No significant differences between the two groups were found in terms of other hospitalization data (P>0.05). CONCLUSION: The total number of patients who received radiotherapy decreased during the epidemic period, but the proportion of head and neck cancer increased. The epidemic had no significant effect on other hospitalization data. While strengthening prevention and control measures, we should actively perform radiotherapy to ensure that cancer patients receive timely and safe treatment. Dove 2021-01-07 /pmc/articles/PMC7800447/ /pubmed/33442292 http://dx.doi.org/10.2147/CMAR.S281323 Text en © 2021 He et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research He, Jian Yang, Liping Tao, Zhenchao Yang, Jing Zhou, Yan Wang, Ru Zhang, Yangyang Huang, Yifan Zhou, Lingran Sun, Bin Gao, Jin Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study |
title | Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study |
title_full | Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study |
title_fullStr | Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study |
title_full_unstemmed | Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study |
title_short | Impact of the 2019 Novel Coronavirus Disease (COVID-19) Epidemic on Radiotherapy-Treated Patients with Cancer: A Single-Center Descriptive Study |
title_sort | impact of the 2019 novel coronavirus disease (covid-19) epidemic on radiotherapy-treated patients with cancer: a single-center descriptive study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800447/ https://www.ncbi.nlm.nih.gov/pubmed/33442292 http://dx.doi.org/10.2147/CMAR.S281323 |
work_keys_str_mv | AT hejian impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy AT yangliping impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy AT taozhenchao impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy AT yangjing impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy AT zhouyan impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy AT wangru impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy AT zhangyangyang impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy AT huangyifan impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy AT zhoulingran impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy AT sunbin impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy AT gaojin impactofthe2019novelcoronavirusdiseasecovid19epidemiconradiotherapytreatedpatientswithcancerasinglecenterdescriptivestudy |